COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review

H A Tehrani; M Darnahal; S A Nadji; S Haghighi

doi:10.1016/j.nmni.2020.100830

COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review

New Microbes New Infect. 2020 Dec 5:39:100830. doi: 10.1016/j.nmni.2020.100830. eCollection 2021 Jan.

Authors

H A Tehrani¹, M Darnahal¹, S A Nadji², S Haghighi¹

Affiliations

¹ Department of Haematology and Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
² Virology Research Center, National Research Institute for Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Coronavirus disease 2019 (COVID-19) pandemic has affected more than 40 million people worldwide. Some patients had episodes of symptom recurrence after the first episode of infection with variable intervals. There are multiple issues and hypotheses about re-infection or re-activation of the virus, especially in immunocompromised patients. In this paper, we present details of an individual with a recent history of COVID-19 who proceeded to acute myeloid leukaemia M3 and immunosuppression by chemotherapy, then we review some recently published articles about possible re-infection or re-activation.

Keywords: Acute myeloid leukaemia; coronavirus disease-19; re-infection.

Publication types

Review